BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 27335717)

  • 21. Stereotactic Radiosurgery for Primary Central Nervous System Lymphoma.
    Wu SY; Braunstein SE; Rubenstein JL; Sneed PK
    Cureus; 2023 Feb; 15(2):e34817. PubMed ID: 36915845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.
    Patil CG; Pricola K; Sarmiento JM; Garg SK; Bryant A; Black KL
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD006121. PubMed ID: 28945270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of Failure after Stereotactic Radiosurgery of the Resection Cavity Following Surgical Removal of Brain Metastases.
    Strauss I; Corn BW; Krishna V; Shahar T; Matceyevsky D; Gez E; Shtraus N; Ram Z; Kanner AA
    World Neurosurg; 2015 Dec; 84(6):1825-31. PubMed ID: 26283490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
    Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
    Lancet Oncol; 2017 Aug; 18(8):1049-1060. PubMed ID: 28687377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes in patients with brain metastases from breast cancer treated with single-session radiosurgery or whole brain radiotherapy.
    Mix M; Elmarzouky R; O'Connor T; Plunkett R; Prasad D
    J Neurosurg; 2016 Dec; 125(Suppl 1):26-30. PubMed ID: 27903186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-institutional competing risks analysis of distant brain failure and salvage patterns after upfront radiosurgery without whole brain radiotherapy for brain metastasis.
    McTyre E; Ayala-Peacock D; Contessa J; Corso C; Chiang V; Chung C; Fiveash J; Ahluwalia M; Kotecha R; Chao S; Attia A; Henson A; Hepel J; Braunstein S; Chan M
    Ann Oncol; 2018 Feb; 29(2):497-503. PubMed ID: 29161348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases?
    Kim KH; Lee J; Lee JI; Nam DH; Kong DS; Ahn YC; Park HC; Kwon OJ; Kim H; Chang MH; Yi SY; Ji SH; Park YH; Ahn JS; Park K; Ahn MJ
    Lung Cancer; 2010 May; 68(2):258-63. PubMed ID: 19592127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors for long-term survival free from whole brain radiation therapy in patients treated with radiosurgery for limited brain metastases.
    Gorovets D; Rava P; Ebner DK; Tybor DJ; Cielo D; Puthawala Y; Kinsella TJ; DiPetrillo TA; Wazer DE; Hepel JT
    Front Oncol; 2015; 5():110. PubMed ID: 26029666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection-Outcome, Prognostic Factors, and Recurrence Patterns.
    El Shafie RA; Dresel T; Weber D; Schmitt D; Lang K; König L; Höne S; Forster T; von Nettelbladt B; Eichkorn T; Adeberg S; Debus J; Rieken S; Bernhardt D
    Front Oncol; 2020; 10():693. PubMed ID: 32477942
    [No Abstract]   [Full Text] [Related]  

  • 30. Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1-4 brain metastases.
    Liu Y; Alexander BM; Chen YH; Horvath MC; Aizer AA; Claus EB; Dunn IF; Golby AJ; Johnson MD; Friesen S; Mannarino EG; Wagar M; Hacker FL; Arvold ND
    J Neurooncol; 2015 Sep; 124(3):429-37. PubMed ID: 26108659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.
    Brown PD; Jaeckle K; Ballman KV; Farace E; Cerhan JH; Anderson SK; Carrero XW; Barker FG; Deming R; Burri SH; Ménard C; Chung C; Stieber VW; Pollock BE; Galanis E; Buckner JC; Asher AL
    JAMA; 2016 Jul; 316(4):401-409. PubMed ID: 27458945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical Resection of Brain Metastases and the Risk of Leptomeningeal Recurrence in Patients Treated With Stereotactic Radiosurgery.
    Johnson MD; Avkshtol V; Baschnagel AM; Meyer K; Ye H; Grills IS; Chen PY; Maitz A; Olson RE; Pieper DR; Krauss DJ
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):537-43. PubMed ID: 26867883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The strategy of repeat stereotactic radiosurgery without whole brain radiation treatment for new brain metastases: Outcomes and implications for follow-up monitoring.
    Shen CJ; Rigamonti D; Redmond KJ; Kummerlowe MN; Lim M; Kleinberg LR
    Pract Radiat Oncol; 2016; 6(6):409-416. PubMed ID: 27687187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotactic radiosurgery for intraventricular brain metastases.
    Farnia B; Voong KR; Brown PD; Allen PK; Guha-Thakurta N; Prabhu SS; Rao G; Wang Q; Zhao Z; Mahajan A
    J Neurosurg; 2014 Dec; 121 Suppl():26-34. PubMed ID: 25434934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereotactic radiosurgery for patients with "radioresistant" brain metastases.
    Brown PD; Brown CA; Pollock BE; Gorman DA; Foote RL
    Neurosurgery; 2008 Feb; 62 Suppl 2():790-801. PubMed ID: 18596426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.
    Patil CG; Pricola K; Garg SK; Bryant A; Black KL
    Cochrane Database Syst Rev; 2010 Jun; (6):CD006121. PubMed ID: 20556764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiosurgery for brainstem metastases with and without whole brain radiotherapy: clinical series and literature review.
    Murray L; Menard C; Zadeh G; Au K; Bernstein M; Millar BA; Laperriere N; Chung C
    J Radiat Oncol; 2017; 6(1):21-30. PubMed ID: 28367275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management approach for recurrent brain metastases following upfront radiosurgery may affect risk of subsequent radiation necrosis.
    Rae A; Gorovets D; Rava P; Ebner D; Cielo D; Kinsella TJ; DiPetrillo TA; Hepel JT
    Adv Radiat Oncol; 2016; 1(4):294-299. PubMed ID: 28740900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant therapy after resection of brain metastases. Frameless image-guided LINAC-based radiosurgery and stereotactic hypofractionated radiotherapy.
    Broemme J; Abu-Isa J; Kottke R; Beck J; Wiest R; Malthaner M; Schmidhalter D; Raabe A; Aebersold DM; Pica A
    Strahlenther Onkol; 2013 Sep; 189(9):765-70. PubMed ID: 23934329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiosurgery to the Postoperative Tumor Bed for Metastatic Carcinoma Versus Whole Brain Radiation After Surgery.
    Scheitler-Ring K; Ge B; Petroski G; Biedermann G; Litofsky NS
    Cureus; 2016 Nov; 8(11):e885. PubMed ID: 28003949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.